Experimental Hematology
Volume 36, Issue 9 , Pages 1132-1142 , September 2008

montalcino, A zebrafish model for variegate porphyria

  • Kimberly A. Dooley

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
    • Current address: Broad Institute/MIT, Cambridge, MA, USA.
    • Corresponding Author InformationOffprint requests to: Leonard I. Zon, M.D., Howard Hughes Medical Institute, Children's Hospital of Boston, Boston, MA 02115
  • ,
  • Paula G. Fraenkel

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
    • Current address: Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • ,
  • Nathaniel B. Langer

      Affiliations

    • Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass., USA
  • ,
  • Bettina Schmid

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Alan J. Davidson

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
    • Current address: Massachusetts General Hospital, Boston, MA, USA.
  • ,
  • Gerhard Weber

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Ken Chiang

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Helen Foott

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Caitlin Dwyer

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Rebecca A. Wingert

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
    • Current address: Massachusetts General Hospital, Boston, MA, USA.
  • ,
  • Yi Zhou

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Barry H. Paw

      Affiliations

    • Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass., USA
  • ,
  • Leonard I. Zon

      Affiliations

    • Division of Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston, Mass., USA
  • ,
  • Tübingen 2000 Screen Consortium

      Affiliations

    • Tübingen 2000 Screen Consortium: F. Bebber van, E. Busch-Nentwich, R. Dahm, H. G. Frohnhöfer, H. Geiger, D. Gilmour, S. Holley, J. Hooge, D. Jülich, H. Knaut, F. Maderspacher, C. Neumann, T. Nicolson, C. Nüsslein-Volhard, H. Roehl, U. Schönberger, C. Seiler, C. Söllner, M. Sonawane, A. Wehner, C. Weiler and B. Schmid at the Max-Planck-Institut für Entwicklungsbiologie, Spemannstrasse 35, 72076 Tübingen, Germany. U. Hagner, E. Hennen, C. Kaps, A. Kirchner, T. I. Koblizek, U. Langheinrich, C. Metzger, R. Nordin, M. Pezzuti, K. Schlombs, J. deSantana-Stamm, T. Trowe, G. Vacun, A. Walker, and C. Weiler at Artemis Pharmaceuticals/Exelixis Deutchland GmbH, Neurather Ring 1, S51063 Köln, Germany.

Received 7 November 2007 ,Revised 27 February 2008 ,Accepted 15 April 2008.

References 

  1. Sassa S. The porphyrias. Photodermatol Photoimmunol Photomed. 2002;18:56–67
  2. Sassa S. Hematological aspects of the porphyrias. Int J Hematol. 2000;71:1–17
  3. Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin Liver Dis. 2004;8:807–838
  4. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142:439–450
  5. Detrich HW, Kieran MW, Chan FY, et al. Intraembryonic hematopoietic cell migration during vertebrate development. Proc Natl Acad Sci U S A. 1995;92:10713–10717
  6. Thompson MA, Ransom DG, Pratt SJ, et al. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev Biol. 1998;197:248–269
  7. Liao EC, Paw BH, Oates AC, Pratt SJ, Postlethwait JH, Zon LI. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev. 1998;12:621–626
  8. Hanaoka R, Katayama S, Dawid IB, Kawahara A. Characterization of the heme synthesis enzyme coproporphyrinogen oxidase (CPO) in zebrafish erythrogenesis. Genes Cells. 2006;11:293–303
  9. Childs S, Weinstein BM, Mohideen MA, Donohue S, Bonkovsky H, Fishman MC. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr Biol. 2000;10:1001–1004
  10. Wang H, Long Q, Marty SD, Sassa S, Lin S. A zebrafish model for hepatoerythropoietic porphyria. Nat Genet. 1998;20:239–243
  11. Westerfield M. The Zebrafish Book. Eugene, OR: University of Oregon Press; 1993;
  12. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev Dyn. 1995;203:253–310
  13. Ransom DG, Haffter P, Odenthal J, et al. Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development. 1996;123:311–319
  14. Zhang J, Talbot WS, Schier AF. Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell. 1998;92:241–251
  15. Johnson SL, Midson CN, Ballinger EW, Postlethwait JH. Identification of RAPD primers that reveal extensive polymorphisms between laboratory strains of zebrafish. Genomics. 1994;19:152–156
  16. Farr CJ, Saiki RK, Erlich HA, McCormick F, Marshall CJ. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci U S A. 1988;85:1629–1633
  17. Weber GJ, Choe SE, Dooley KA, Paffett-Lugassy NN, Zhou Y, Zon LI. Mutant-specific gene programs in the zebrafish. Blood. 2005;106:521–530
  18. Donovan A, Brownlie A, Dorschner MO, et al. The zebrafish mutant gene chardonnay (cdy) encodes divalent metal transporter 1 (DMT1). Blood. 2002;100:4655–4659
  19. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776–781
  20. Wingert RA, Galloway JL, Barut B, et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005;436(7053):1035–1039
  21. Wingert RA, Brownlie A, Galloway JL, et al. The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1. Development. 2004;131:6225–6235
  22. Wiman A, Harper P, Floderus Y. Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish families with variegate porphyria. Clin Genet. 2003;64:122–130
  23. von und zu Fraunberg M, Timonen K, Mustajoki P, Kauppinen R. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. Eur J Hum Genet. 2002;10:649–657
  24. Koch M, Breithaupt C, Kiefersauer R, Freigang J, Huber R, Messerschmidt A. Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis. EMBO J. 2004;23:1720–1728
  25. Brownlie A, Donovan A, Pratt SJ, et al. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet. 1998;20:244–250
  26. Liao EC, Paw BH, Peters LL, et al. Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid beta-spectrin structure, and function in red cell morphogenesis and membrane stability. Development. 2000;127:5123–5132
  27. Brownlie A, Hersey C, Oates AC, et al. Characterization of embryonic globin genes of the zebrafish. Dev Biol. 2003;255:48–61
  28. Verma A, Nye JS, Snyder SH. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc Natl Acad Sci U S A. 1987;84:2256–2260
  29. Cantoni L, Rizzardini M, Skorupska M, et al. Hepatic protoporphyria is associated with a decrease in ligand binding for the mitochondrial benzodiazepine receptors in the liver. Biochem Pharmacol. 1992;44:1159–1164
  30. Wendler G, Lindemann P, Lacapere JJ, Papadopoulos V. Protoporphyrin IX binding and transport by recombinant mouse PBR. Biochem Biophys Res Commun. 2003;311:847–852
  31. Meissner PN, Dailey TA, Hift RJ, et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet. 1996;13:95–97
  32. Roberts AG, Puy H, Dailey TA, et al. Molecular characterization of homozygous variegate porphyria. Hum Mol Genet. 1998;7:1921–1925
  33. Paw BH, Davidson AJ, Zhou Y, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet. 2003;34:59–64
  34. Papadopoulos V. In search of the function of the peripheral-type benzodiazepine receptor. Endocr Res. 2004;30:677–684
  35. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629–650
  36. Handschin C, Lin J, Rhee J, et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell. 2005;122:505–515
  37. Wingert RA, Galloway JL, Barut B, et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005;436(7053):1035–1039

PII: S0301-472X(08)00179-3

doi: 10.1016/j.exphem.2008.04.008

Experimental Hematology
Volume 36, Issue 9 , Pages 1132-1142 , September 2008